A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy and safety of intravenous Avastin in combination with
chemotherapy regimens as second-line treatment of metastatic cancer of the colon or rectum.
The anticipated time of study treatment is until disease progression.